NEW DELHI: Pharmaceutical giant Pfizer on Wednesday said that its Covid-19 vaccine candidate was found to be 95 per cent effective in the final analysis of the Phase 3 trial, adding it had the required two-months of safety data and would apply for emergency US authorisation within days. The drugmaker said the efficacy of the vaccine developed with German partner BioNTech SE was consistent across age and ethnicity demographics, and that there were no major side effects.
West Bengal Chief Minister Mamata Banerjee on Thursday criticised RSS chief Mohan Bhagwat’s recent statement…
President Yoon's refusal to cooperate with questioning follows his arrest amid a probe into his…
AAP National Convenor Arvind Kejriwal strongly condemned the fatal attack on Bollywood actor Saif Ali…
A severe cold wave is gripping North India, bringing dense fog, heavy rains, and freezing…
Most of the WMF list includes sites in conflict zones, such as Ukraine and Gaza,…
After the RDX blast took place at the residence of Punjab Congress leader from Batala,…